API - Katalog
- Abarelix
- Calcitonin
- Liraglutide
No YGP001
English Name: Abarelix
Cas No.: 183552-38-7
Scale: R&D
Specification: In-house
Documentation: DMF, USP, EP, Ch.P. and CoA
JYGP002
Alarelin
79561-22-1
R&D
In-house
JYGP003
Atosiban [593 KB]
90779-69-4
Commercial
In-house
DMF Available
JYGP004
Aviptadil
40077-57-4
R&D
In-house
JYGP005
Angiotensin II
4474-91-3
R&D
In-house
JYGP006
Antide
112568-12-4
R&D
In-house
JYGP007
Vasopressin
11000-17-2
Commercial
USP
JYGP008
Bivalirudin
128270-60-0
Commercial
In-house
DMF Available
JYGP009
Buserelin Acetate
68630-75-1
Commercial
EP
JYGP011
Calcitonin (Salmon)
47931-85-1
Pilot
EP
JYGP012
Carbetocin
37025-55-1
Commercial
In-house
DMF Available
JYGP013
Carperitide
89213-87-6
R&D
In-house
JYGP014
Cetrorelix Acetate
120287-85-6
Pilot
In-house
JYGP015
Desmopressin Acetate
16789-98-3
Commercial
EP/FDA
DMF Available
JYGP016
Deslorelin [614 KB]
57773-65-6
Commercial
In-house
JYGP017
Elcatonin
57014-02-5
R&D
In-house
JYGP018
Enfuvirtide
159519-65-0
R&D
In-house
JYGP019
Eptifibatide Acetate
148031-34-9
Pilot
EP
JYGP020
Exenatide Acetate
141758-74-9
Commercial
In-house
JYGP021
Fertirelin Acetate
66002-66-2
R&D
In-house
JYGP022
GLP-1(7-36) amide
107444-51-9
R&D
In-house
JYGP023
GLP-1 (7-37)
106612-94-6
R&D
In-house
JYGP024
Glucagon
16941-32-5
Pilot
EP/USP
JYGP025
Gonadorelin Acetate
71447-49-9
Pilot
EP
JYGP026
Goserelin Acetate
145781-92-6
Commercial
EP/USP
DMF Preparation
JYGP027
Histrelin Acetate
220810-26-4
Commercial
In-house
JYGP028
Icatibant
30308-48-4
R&D
In-house
JYGP029
Leuprorelin Acetate
74381-53-6
Commercial
USP
JYGP030
Lanreotide Acetate
108736-35-2
R&D
In-house
JYGP031
Liraglutide [649 KB]
204656-20-2
Commercial
In-house
DMF Preparation
JYGP032
Lysipressin
50-57-7
Commercial
In-house
JYGP033
Nafarelin
86220-42-0
R&D
In-house
JYGP034
Octreotide Acetate
79517-01-4
Pilot
Ch.P/EP
JYGP035
Oxytocin
50-56-6
Commercial
EP/USP
DMF Available
JYGP036
Pramlintide Acetate
196078-30-5
Pilot
In-house
JYGP037
Protirelin
24305-27-9
Commercial
EP
JYGP038
Sincalide Acetate
25126-32-3
R&D
USP
JYGP039
Somatostatin
38916-34-6
Commercial
EP/Ch.P
JYGP040
Terlipressin [585 KB]
14636-12-5
Commercial
EP/In-house
DMF Available
JYGP041
Teriparatide Acetate
52232-67-4
R&D
In-house
JYGP042
Thymopentin Acetate
177966-81-3
Commercial
Ch.P
JYGP043
Thymosin β4 Acetate
77591-33-4
R&D
In-house
JYGP044
Thymalfasin
62304-98-7
Commercial
Ch.P
JYGP045
Triptorelin Acetate
140194-24-7
Commercial
In-house
JYGP047
Linaclotide Acetate
851199-60-5
R&D
In-house
JYGP048
Degarelix
214766-78-6
Pilot
In-house
DMF Preparation
Zugriffe heute: 1 - gesamt: 2561.